Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,810.00    100.00 (1.75%)
Bid:
5,795.00
Ask:
5,805.00
Spread: 10.00 (0.173%)
Market Cap: $1.53t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Spin-off Completion Report

4 Nov 2016 09:05

RNS Number : 3614O
Samsung Electronics Co. Ld
04 November 2016
 

Spin-off Completion Report

 

. Timeline

 

Event

Date

Resolution of Board of Directors

09/12/2016

Issue of Spin-off report

09/12/2016

Submission of Decision on Spin-off Report

09/12/2016

Finalizing the shareholder list

09/28/2016

Closure of Share transfer book

Start date

09/29/2016

End date

10/04/2016

Extraordinary General Meeting of Shareholders

for the approval of Spin-off report

10/27/2016

Spin-off

11/01/2016

General assembly of corporate division report and inaugural meeting

11/02/2016

Spin-off registration

11/04/2016

(Note) The general assembly of corporate division report or inaugural meeting provided above was replaced

with the notice and resolution of Board of Directors.

 

. Change in stock or ratio of shares owned by major shareholders

Not applicable as this transaction constitutes a straight spin-off

 

. Appraisal rights of shareholders

Not applicable as this transaction constitutes a straight spin-off

 

. Protection of creditors

According to Paragraph 1 of Article 530-9 of the Commercial Act, Samsung Electronics Co., Ltd.

(hereinafter referred to as "the Company"), and S-Printing Solution Co., Ltd. (hereinafter referred to

as "the New Corp.") shall be jointly liable for liabilities of the Company that existed prior to spin-off.

 

. Relevant lawsuits

As of the date of this report, no lawsuits that can affect the validity of the spin-off have been filed.

 

. New shares allotment

As this transaction constitutes a straight spin-off, 100% of the shares issued by the New Corp were

allotted to the Company.

 

. Pre/Post Spin-Off Financial Position

Pre/Post Spin-Off Financial Position (June 30, 2016)

 

(Unit:KRW million)

Item

Pre spin-off

Post spin-off

Surviving entity

New entity

I. Assets

163,313,133

163,103,998

347,658

1. Current assets

65,317,792

65,070,212

247,580

2. Non-current assets

97,995,341

98,033,786

100,077

II. Liabilities

30,303,810

30,094,675

209,135

1. Current liabilities

26,742,315

26,613,443

128,872

2. Non-current liabilities

3,561,495

3,481,232

80,263

III. Equity

133,009,323

133,009,323

138,523

1. Equities

897,514

897,514

50,000

2. Share premium

4,403,893

4,403,893

88,523

3. Retained earnings

138,556,832

138,556,832

- 

4. Other components of equity

-10,848,916

-10,848,916

- 

(Note) The above figures are based on the financial position as of June 30, 2016 and can be adjusted in

accordance with business circumstances by the date of spin-off.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKZLBBQFFBFBL
Date   Source Headline
31st Oct 20249:02 amRNSDelisting and Listing of Stocks
31st Oct 20247:00 amRNSAnnouncement of Capex Plan for FY2024
31st Oct 20247:00 amRNS2024 3Q Earnings Release
31st Oct 20247:00 amRNSQuarterly Dividend for Third Quarter 2024
8th Oct 20247:00 amRNSNotice of 3Q 2024 Earning Release
8th Oct 20247:00 amRNS3Q 2024 Pre-Earnings Guidance
30th Aug 202410:52 amRNS2024 Half-year Business Report
31st Jul 20249:33 amRNSTransaction with Affiliate Company
31st Jul 20249:26 amRNSCharitable Contribution
31st Jul 20247:00 amRNS2024 2Q Earnings Release
31st Jul 20247:00 amRNSQuarterly Dividend for Second Quarter 2024
5th Jul 20247:55 amRNSNotice of 2Q 2024 Earnings Release Schedule
5th Jul 20247:45 amRNS2Q 2024 Pre-Earnings Guidance
28th Jun 20248:53 amRNSSustainability Report 2024
31st May 202410:23 amRNSCorporate Governance Report FY2023
31st May 20247:00 amRNS2024 1Q INTERIM BUSINESS REPORT
21st May 20249:34 amRNSNotice on Change of CEO
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.